Cargando…

Immunotherapy for pancreatic cancer

Pancreatic cancer, a highly lethal cancer, has the lowest 5-year survival rate for several reasons, including its tendency for the late diagnosis, a lack of serologic markers for screening, aggressive local invasion, its early metastatic dissemination, and its resistance to chemotherapy/radiotherapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoon, Jai Hoon, Jung, Ye-Ji, Moon, Sung-Hoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080736/
https://www.ncbi.nlm.nih.gov/pubmed/33969083
http://dx.doi.org/10.12998/wjcc.v9.i13.2969